Prader-Willi syndrome due to imprinting mutation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:177910OMIM:176270Q87.1
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Prader-Willi syndrome due to imprinting mutation (also called Prader-Willi syndrome due to imprinting defect or epimutation) is a specific genetic subtype of Prader-Willi syndrome (PWS) caused by abnormal DNA methylation (an epigenetic defect) in the Prader-Willi critical region on chromosome 15q11-q13. In this subtype, both copies of chromosome 15 are present and structurally normal, but the paternal copy carries an abnormal imprinting pattern that silences genes that should normally be active. This imprinting defect accounts for approximately 1–3% of all Prader-Willi syndrome cases. The clinical features are consistent with those seen in other forms of Prader-Willi syndrome. In the neonatal period, affected infants typically present with severe hypotonia (low muscle tone), feeding difficulties, and failure to thrive. During early childhood, the clinical picture shifts dramatically to hyperphagia (an insatiable appetite) and progressive obesity if caloric intake is not strictly controlled. Additional features include short stature, hypogonadism, intellectual disability (usually mild to moderate), behavioral problems (such as temper tantrums, stubbornness, and obsessive-compulsive tendencies), and characteristic facial features including a narrow forehead, almond-shaped eyes, and a thin upper lip. Multiple body systems are affected, including the endocrine, neurological, musculoskeletal, and reproductive systems. There is no cure for Prader-Willi syndrome due to imprinting mutation. Management is multidisciplinary and includes growth hormone therapy to improve height, body composition, and muscle tone; strict dietary supervision to prevent life-threatening obesity; sex hormone replacement for hypogonadism; and behavioral, educational, and psychological support. Early intervention with physical therapy, speech therapy, and occupational therapy can improve developmental outcomes. Notably, some imprinting defect cases occur without a detectable microdeletion in the imprinting center, and these cases may have a lower recurrence risk compared to those with an identifiable imprinting center deletion, which is an important consideration for genetic counseling.

Clinical phenotype terms— hover any for plain English:

Abnormal ulnar metaphysis morphologyHP:0004039Narrow palmHP:0004283External genital hypoplasiaHP:0003241
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Voranigo

vorasidenib· Servier Pharmaceuticals LLC
indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrog

indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, as detected by an FDA-approved test, following surgery including biopsy, sub-total resection, or gross total resection

No actively recruiting trials found for Prader-Willi syndrome due to imprinting mutation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Prader-Willi syndrome due to imprinting mutation community →

No specialists are currently listed for Prader-Willi syndrome due to imprinting mutation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Prader-Willi syndrome due to imprinting mutation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Prader-Willi syndrome due to imprinting mutationForum →

No community posts yet. Be the first to share your experience with Prader-Willi syndrome due to imprinting mutation.

Start the conversation →

Latest news about Prader-Willi syndrome due to imprinting mutation

No recent news articles for Prader-Willi syndrome due to imprinting mutation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Prader-Willi syndrome due to imprinting mutation

What is Prader-Willi syndrome due to imprinting mutation?

Prader-Willi syndrome due to imprinting mutation (also called Prader-Willi syndrome due to imprinting defect or epimutation) is a specific genetic subtype of Prader-Willi syndrome (PWS) caused by abnormal DNA methylation (an epigenetic defect) in the Prader-Willi critical region on chromosome 15q11-q13. In this subtype, both copies of chromosome 15 are present and structurally normal, but the paternal copy carries an abnormal imprinting pattern that silences genes that should normally be active. This imprinting defect accounts for approximately 1–3% of all Prader-Willi syndrome cases. The cli

At what age does Prader-Willi syndrome due to imprinting mutation typically begin?

Typical onset of Prader-Willi syndrome due to imprinting mutation is neonatal. Age of onset can vary across affected individuals.